Evidence map›Paper›PMID 32104326›Full record

ArticleAsian journal of pharmaceutical sciences2017

Investigation of Linarinic acid and one of its derivatives against cerebral ischemia in mice.

Yihan Wang, Chao Zhao, Qiujv Wang, Huimin Wen, Yaru Gu, Linlin Fan, Chao Ma, Maosheng Cheng, Yuyang Zhang

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Asian journal of pharmaceutical sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yihan WangSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, No.103,Wenhua Road, Shenyang 110016, China.
Chao ZhaoSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, No.103,Wenhua Road, Shenyang 110016, China.
Qiujv WangSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, No.103,Wenhua Road, Shenyang 110016, China.
Huimin WenSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, No.103,Wenhua Road, Shenyang 110016, China.
Yaru GuSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, No.103,Wenhua Road, Shenyang 110016, China.
Linlin FanSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, No.103,Wenhua Road, Shenyang 110016, China.
Chao MaSchool of Pharmaceutical Engineering, Shenyang Pharmaceutical University, No.103, Wenhua Road, Shenyang 110016, China.
Maosheng ChengSchool of Pharmaceutical Engineering, Shenyang Pharmaceutical University, No.103, Wenhua Road, Shenyang 110016, China.
Yuyang ZhangSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, No.103,Wenhua Road, Shenyang 110016, China.
Shenyang Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study aims to investigate the effects of (-)-Linarinic acid (LA) and one of its derivatives (LA

Indexed as

Cerebral ischemia(-)-Linarinic acidMalonaldehydeMice

Identifiers

PMID32104326
PMCPMC7032232
OpenAlexW2482295816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.